lenvatinib and macitentan

lenvatinib has been researched along with macitentan* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and macitentan

Article	Year
Successful Management With Dual Therapy of Lenvatinib and Macitentan for HCC With Portopulmonary Hypertension. Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4 Topics: Aged; Carcinoma, Hepatocellular; Cardiac Catheterization; Endothelin Receptor Antagonists; Hepatitis B, Chronic; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Neoplasms; Male; Medication Therapy Management; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Arterial Hypertension; Pyrimidines; Quinolines; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome	2021

Article

Year

Successful Management With Dual Therapy of Lenvatinib and Macitentan for HCC With Portopulmonary Hypertension.

Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4

Topics: Aged; Carcinoma, Hepatocellular; Cardiac Catheterization; Endothelin Receptor Antagonists; Hepatitis B, Chronic; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Neoplasms; Male; Medication Therapy Management; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Arterial Hypertension; Pyrimidines; Quinolines; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome

2021